Asset Planning Services (Pennsylvania)’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-15,421
Closed -$11K 76
2020
Q4
$11K Hold
15,421
0.01% 70
2020
Q3
$35K Hold
15,421
0.02% 81
2020
Q2
$55K Hold
15,421
0.02% 79
2020
Q1
$59K Hold
15,421
0.03% 75
2019
Q4
$51K Buy
+15,421
New +$40.1K 0.02% 76

Other funds holding BMY.RT

Asset Planning Services (Pennsylvania)'s BMY.RT Position: Q1 2021 in Review

Asset Planning Services (Pennsylvania) sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 15,421 shares — an estimated $11K sold.

Asset Planning Services (Pennsylvania) first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $59K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Asset Planning Services (Pennsylvania) reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Asset Planning Services (Pennsylvania) sold 15,421 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $11K.
  • Asset Planning Services (Pennsylvania) first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Asset Planning Services (Pennsylvania)'s Bristol-Myers Squibb Company Contingent Value Rights position peaked at $59K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Asset Planning Services (Pennsylvania)'s 13F filing for Q1 2021, filed 11 May 2021.